Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy
Clinical trial NCT04827875 · COMPLETED
Trial details
- NCT number
- NCT04827875
- Sponsor
- AiViva BioPharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-23
- Primary completion
- 2022-12-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.